Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services
Launched by RHODE ISLAND HOSPITAL · Jan 9, 2025
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a program called SPARE, which stands for Social Skills, Problem Solving, Emotion Regulation, and Psycho-Education on Trauma. The goal of the study is to see if this program can help reduce aggressive behaviors and prevent dating violence among preteens who are receiving intensive mental health services. Researchers want to find out if participating in SPARE can lead to less aggressive behavior and improve attitudes toward dating violence, as well as overall mental health, both immediately after the program and at follow-up assessments three and nine months later.
To be eligible for the trial, participants need to be between 11 to 13 years old, enrolled in the mental health program, able to speak and write in English, and have permission from a parent or guardian. Those who join will take part in group therapy sessions as part of their daily routine in the program. They will also fill out questionnaires at the start and end of the program, and again three and nine months later, to help researchers understand the program's impact. This study is currently recruiting participants, and both boys and girls are welcome to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • (1) aged 11-13 years
- • (2) enrolled in CP,
- • (3) ability to write and speak in English
- • (4) parent/guardian consent.
- Exclusion Criteria:
- • None
About Rhode Island Hospital
Rhode Island Hospital, a leading academic medical center and a key component of the Lifespan health system, is committed to advancing medical research and improving patient care through innovative clinical trials. As a principal teaching hospital for The Warren Alpert Medical School of Brown University, it integrates cutting-edge research with high-quality clinical services. The hospital's extensive clinical trial program spans various fields, including oncology, cardiology, neurology, and more, aiming to enhance treatment options and patient outcomes. By fostering collaboration among researchers, clinicians, and patients, Rhode Island Hospital plays a pivotal role in translating scientific discoveries into effective therapies and improving healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Patients applied
Trial Officials
Elizabeth C Tampke, PhD
Principal Investigator
Rhode Island Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported